Global Epilepsy Therapeutics Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 09-Jul-2019
No. of pages: 93
Inquire Before Buying

Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characterized by brief and undetectable episodes of involuntary movement involving either a body part (partial) or the entire body (generalized).

Neurological disorders treatment market is growing at a significant rate, due to increasing prevalence of neurological disorders and technological advancements in the treatment of these conditions.

United States dominates the global market for epilepsy therapeutics due to increasing prevalence of epilepsy cases in the region.

China and India are expected to be the fastest growing epilepsy therapeutics markets in the Asia. This is due to the large population base and increasing prevalence of epilepsy cases in these countries.

In 2018, the global Epilepsy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Epilepsy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epilepsy Therapeutics development in United States, Europe and China.

The key players covered in this study

- Abbott Laboratories

- Cephalon

- Novartis

- Pfizer

- Johnson & Johnson

- GlaxoSmithKline

- Sanofi

- Sunovion Pharmaceuticals

- Valeant Pharmaceuticals

- Shire

Market segment by Type, the product can be split into

- Anti-epileptic Drugs

- Dietary Supplements

- Vagal Nerve Stimulation

- Surgical Therapies

Market segment by Application, split into

- Hospitals

- Neurology Centers

- Home Care Settings

- Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Epilepsy Therapeutics status, future forecast, growth opportunity, key market and key players.

- To present the Epilepsy Therapeutics development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Epilepsy Therapeutics are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Epilepsy Therapeutics Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Epilepsy Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-epileptic Drugs
1.4.3 Dietary Supplements
1.4.4 Vagal Nerve Stimulation
1.4.5 Surgical Therapies
1.5 Market by Application
1.5.1 Global Epilepsy Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Neurology Centers
1.5.4 Home Care Settings
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Epilepsy Therapeutics Market Size
2.2 Epilepsy Therapeutics Growth Trends by Regions
2.2.1 Epilepsy Therapeutics Market Size by Regions (2014-2025)
2.2.2 Epilepsy Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Epilepsy Therapeutics Market Size by Manufacturers
3.1.1 Global Epilepsy Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Epilepsy Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Epilepsy Therapeutics Key Players Head office and Area Served
3.3 Key Players Epilepsy Therapeutics Product/Solution/Service
3.4 Date of Enter into Epilepsy Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Epilepsy Therapeutics Market Size by Type (2014-2019)
4.2 Global Epilepsy Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Epilepsy Therapeutics Market Size (2014-2019)
5.2 Epilepsy Therapeutics Key Players in United States
5.3 United States Epilepsy Therapeutics Market Size by Type
5.4 United States Epilepsy Therapeutics Market Size by Application
6 Europe
6.1 Europe Epilepsy Therapeutics Market Size (2014-2019)
6.2 Epilepsy Therapeutics Key Players in Europe
6.3 Europe Epilepsy Therapeutics Market Size by Type
6.4 Europe Epilepsy Therapeutics Market Size by Application
7 China
7.1 China Epilepsy Therapeutics Market Size (2014-2019)
7.2 Epilepsy Therapeutics Key Players in China
7.3 China Epilepsy Therapeutics Market Size by Type
7.4 China Epilepsy Therapeutics Market Size by Application
8 Japan
8.1 Japan Epilepsy Therapeutics Market Size (2014-2019)
8.2 Epilepsy Therapeutics Key Players in Japan
8.3 Japan Epilepsy Therapeutics Market Size by Type
8.4 Japan Epilepsy Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Epilepsy Therapeutics Market Size (2014-2019)
9.2 Epilepsy Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Epilepsy Therapeutics Market Size by Type
9.4 Southeast Asia Epilepsy Therapeutics Market Size by Application
10 India
10.1 India Epilepsy Therapeutics Market Size (2014-2019)
10.2 Epilepsy Therapeutics Key Players in India
10.3 India Epilepsy Therapeutics Market Size by Type
10.4 India Epilepsy Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Epilepsy Therapeutics Market Size (2014-2019)
11.2 Epilepsy Therapeutics Key Players in Central & South America
11.3 Central & South America Epilepsy Therapeutics Market Size by Type
11.4 Central & South America Epilepsy Therapeutics Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Epilepsy Therapeutics Introduction
12.1.4 Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Cephalon
12.2.1 Cephalon Company Details
12.2.2 Company Description and Business Overview
12.2.3 Epilepsy Therapeutics Introduction
12.2.4 Cephalon Revenue in Epilepsy Therapeutics Business (2014-2019)
12.2.5 Cephalon Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Epilepsy Therapeutics Introduction
12.3.4 Novartis Revenue in Epilepsy Therapeutics Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Epilepsy Therapeutics Introduction
12.4.4 Pfizer Revenue in Epilepsy Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Epilepsy Therapeutics Introduction
12.5.4 Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Epilepsy Therapeutics Introduction
12.6.4 GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Epilepsy Therapeutics Introduction
12.7.4 Sanofi Revenue in Epilepsy Therapeutics Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Sunovion Pharmaceuticals
12.8.1 Sunovion Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Epilepsy Therapeutics Introduction
12.8.4 Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2014-2019)
12.8.5 Sunovion Pharmaceuticals Recent Development
12.9 Valeant Pharmaceuticals
12.9.1 Valeant Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Epilepsy Therapeutics Introduction
12.9.4 Valeant Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2014-2019)
12.9.5 Valeant Pharmaceuticals Recent Development
12.10 Shire
12.10.1 Shire Company Details
12.10.2 Company Description and Business Overview
12.10.3 Epilepsy Therapeutics Introduction
12.10.4 Shire Revenue in Epilepsy Therapeutics Business (2014-2019)
12.10.5 Shire Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Epilepsy Therapeutics Key Market Segments
Table Key Players Epilepsy Therapeutics Covered
Table Global Epilepsy Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Epilepsy Therapeutics Market Size Market Share by Type 2014-2025
Figure Anti-epileptic Drugs Figures
Table Key Players of Anti-epileptic Drugs
Figure Dietary Supplements Figures
Table Key Players of Dietary Supplements
Figure Vagal Nerve Stimulation Figures
Table Key Players of Vagal Nerve Stimulation
Figure Surgical Therapies Figures
Table Key Players of Surgical Therapies
Table Global Epilepsy Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Neurology Centers Case Studies
Figure Home Care Settings Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Epilepsy Therapeutics Report Years Considered
Table Global Epilepsy Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Epilepsy Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Epilepsy Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Epilepsy Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Epilepsy Therapeutics Market Share by Regions 2014-2019
Figure Global Epilepsy Therapeutics Market Share by Regions 2014-2019
Figure Global Epilepsy Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Epilepsy Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Epilepsy Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Epilepsy Therapeutics Market Share by Manufacturers in 2018
Table Global Epilepsy Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Epilepsy Therapeutics Product/Solution/Service
Table Date of Enter into Epilepsy Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Epilepsy Therapeutics Market Size Share by Type (2014-2019)
Figure Global Epilepsy Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Epilepsy Therapeutics Market Size Share by Application (2014-2019)
Figure Global Epilepsy Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Epilepsy Therapeutics Revenue Market Share by Application in 2018
Figure United States Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table United States Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Epilepsy Therapeutics Market Share by Type (2014-2019)
Table United States Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure Europe Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table Europe Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Epilepsy Therapeutics Market Share by Type (2014-2019)
Table Europe Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure China Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table China Epilepsy Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Epilepsy Therapeutics Market Share by Type (2014-2019)
Table China Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure Japan Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table Japan Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Epilepsy Therapeutics Market Share by Type (2014-2019)
Table Japan Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table Southeast Asia Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Epilepsy Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure India Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table India Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Epilepsy Therapeutics Market Share by Type (2014-2019)
Table India Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table Central & South America Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Epilepsy Therapeutics Market Share by Type (2014-2019)
Table Central & South America Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Epilepsy Therapeutics Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Cephalon Company Details
Table Cephalon Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Cephalon Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Cephalon Recent Development
Table Novartis Company Details
Table Novartis Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Sunovion Pharmaceuticals Company Details
Table Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Sunovion Pharmaceuticals Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Shire Company Details
Table Shire Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Shire Recent Development
Table Global Epilepsy Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Epilepsy Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Epilepsy Therapeutics Market Size Share by Regions in 2025
Figure United States Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Epilepsy Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Epilepsy Therapeutics Market Size by Product (2019-2025)
Figure Global Epilepsy Therapeutics Market Size by Product in 2025
Table Global Epilepsy Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Epilepsy Therapeutics Market Size by Application (2019-2025)
Figure Global Epilepsy Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......
  • Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 110
    Report Overview: Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......
  • Global Epilepsy Therapeutics Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Cephalon - Novartis - Pfizer - Johnson & Johnson - GlaxoSmithKline - Sanofi - Sunovion Pharmaceuticals......
  • Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Autism Spectrum Disorder market: According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
  • Global Autism Spectrum Disorder Market Status and Outlook 2023-2028
    Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 109
    Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......
  • Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Epilepsy Therapeutics market: According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years. Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......
  • Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Gabapentin market: According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......
  • 2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel
    Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Aut......
  • Global Gabapentin Market Insights, Forecast to 2029
    Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 112
    Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs